Thermo Fisher Scientific Inc has a consensus price target of $606.92 based on the ratings of 27 analysts. The high is $680 issued by Redburn Atlantic on October 14, 2024. The low is $470 issued by Argus Research on April 29, 2025. The 3 most-recent analyst ratings were released by Argus Research, Scotiabank, and RBC Capital on April 29, 2025, April 25, 2025, and April 24, 2025, respectively. With an average price target of $570.67 between Argus Research, Scotiabank, and RBC Capital, there's an implied 33.48% upside for Thermo Fisher Scientific Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/29/2025 | Buy Now | 9.93% | Argus Research | David Toung71% | $620 → $470 | Maintains | Buy | Get Alert |
04/25/2025 | Buy Now | 41.51% | Scotiabank | Sung Ji Nam45% | $650 → $605 | Maintains | Sector Perform | Get Alert |
04/24/2025 | Buy Now | 49% | RBC Capital | Conor McNamara38% | $651 → $637 | Maintains | Outperform | Get Alert |
04/24/2025 | Buy Now | 16.95% | UBS | Dan Leonard56% | $715 → $500 | Maintains | Buy | Get Alert |
04/24/2025 | Buy Now | 45.02% | Stifel | Daniel Arias78% | $665 → $620 | Maintains | Buy | Get Alert |
04/24/2025 | Buy Now | 16.95% | Evercore ISI Group | Vijay Kumar51% | $585 → $500 | Maintains | Outperform | Get Alert |
04/24/2025 | Buy Now | 33.32% | Wells Fargo | Brandon Couillard71% | $580 → $570 | Maintains | Overweight | Get Alert |
04/24/2025 | Buy Now | 34.03% | Baird | Catherine Schulte68% | $603 → $573 | Maintains | Outperform | Get Alert |
04/17/2025 | Buy Now | 35.66% | Wells Fargo | Brandon Couillard71% | $680 → $580 | Maintains | Overweight | Get Alert |
04/10/2025 | Buy Now | 11.1% | Barclays | Luke Sergott52% | $620 → $475 | Maintains | Equal-Weight | Get Alert |
03/04/2025 | Buy Now | 33.32% | Citigroup | Patrick Donnelly80% | $650 → $570 | Maintains | Neutral | Get Alert |
02/03/2025 | Buy Now | 52.04% | Scotiabank | Sung Ji Nam45% | $605 → $650 | Maintains | Sector Perform | Get Alert |
02/03/2025 | Buy Now | 56.01% | Raymond James | Andrew Cooper55% | $650 → $667 | Reiterates | Outperform → Outperform | Get Alert |
01/31/2025 | Buy Now | 52.04% | Citigroup | Patrick Donnelly80% | $600 → $650 | Maintains | Neutral | Get Alert |
01/31/2025 | Buy Now | 67.24% | UBS | Dan Leonard56% | $700 → $715 | Maintains | Buy | Get Alert |
01/31/2025 | Buy Now | 59.05% | Wells Fargo | Brandon Couillard71% | $660 → $680 | Maintains | Overweight | Get Alert |
01/31/2025 | Buy Now | 58.59% | Morgan Stanley | Tejas Savant50% | $647 → $678 | Maintains | Overweight | Get Alert |
01/13/2025 | Buy Now | 51.33% | Morgan Stanley | Tejas Savant50% | $670 → $647 | Maintains | Overweight | Get Alert |
12/23/2024 | Buy Now | 41.51% | Scotiabank | Sung Ji Nam45% | → $605 | Initiates | → Sector Perform | Get Alert |
12/13/2024 | Buy Now | 54.38% | B of A Securities | Derik De Bruin83% | $675 → $660 | Maintains | Buy | Get Alert |
10/24/2024 | Buy Now | 45.02% | Bernstein | Eve Burstein44% | $625 → $620 | Maintains | Market Perform | Get Alert |
10/24/2024 | Buy Now | 67.94% | RBC Capital | Conor McNamara38% | $767 → $718 | Maintains | Outperform | Get Alert |
10/24/2024 | Buy Now | 55.54% | Stifel | Daniel Arias78% | $680 → $665 | Maintains | Buy | Get Alert |
10/24/2024 | Buy Now | 45.02% | Evercore ISI Group | Vijay Kumar51% | $630 → $620 | Maintains | Outperform | Get Alert |
10/24/2024 | Buy Now | 54.38% | Wells Fargo | Brandon Couillard71% | $670 → $660 | Maintains | Overweight | Get Alert |
10/24/2024 | Buy Now | 45.49% | Baird | Catherine Schulte68% | $632 → $622 | Maintains | Outperform | Get Alert |
10/23/2024 | Buy Now | 42.68% | Barclays | Luke Sergott52% | $620 → $610 | Maintains | Equal-Weight | Get Alert |
10/15/2024 | Buy Now | 45.02% | Barclays | Luke Sergott52% | $600 → $620 | Maintains | Equal-Weight | Get Alert |
10/14/2024 | Buy Now | 59.05% | Redburn Atlantic | — | → $680 | Initiates | → Buy | Get Alert |
10/01/2024 | Buy Now | 47.36% | Evercore ISI Group | Vijay Kumar51% | $605 → $630 | Maintains | Outperform | Get Alert |
10/01/2024 | Buy Now | 59.05% | Stephens & Co. | Jacob Johnson61% | → $680 | Initiates | → Overweight | Get Alert |
09/20/2024 | Buy Now | 56.71% | JP Morgan | Rachel Vatnsdal65% | $650 → $670 | Maintains | Overweight | Get Alert |
09/20/2024 | Buy Now | 59.05% | Stifel | Daniel Arias78% | $615 → $680 | Maintains | Buy | Get Alert |
09/20/2024 | Buy Now | 79.4% | RBC Capital | Conor McNamara38% | $767 → $767 | Reiterates | Outperform → Outperform | Get Alert |
09/20/2024 | Buy Now | 59.05% | Morgan Stanley | Tejas Savant50% | $655 → $680 | Maintains | Overweight | Get Alert |
09/16/2024 | Buy Now | 57.88% | B of A Securities | Derik De Bruin83% | $600 → $675 | Maintains | Buy | Get Alert |
08/27/2024 | Buy Now | 56.71% | Wells Fargo | Brandon Couillard71% | → $670 | Initiates | → Overweight | Get Alert |
07/25/2024 | Buy Now | 53.91% | TD Cowen | Dan Brennan66% | $648 → $658 | Maintains | Buy | Get Alert |
07/25/2024 | Buy Now | 54.38% | Raymond James | Andrew Cooper55% | $650 → $660 | Maintains | Outperform | Get Alert |
07/25/2024 | Buy Now | 55.31% | RBC Capital | Conor McNamara38% | $660 → $664 | Maintains | Outperform | Get Alert |
07/25/2024 | Buy Now | 43.85% | Stifel | Daniel Arias78% | $600 → $615 | Maintains | Buy | Get Alert |
07/25/2024 | Buy Now | 47.83% | Baird | Catherine Schulte68% | $620 → $632 | Maintains | Outperform | Get Alert |
07/02/2024 | Buy Now | 40.34% | Evercore ISI Group | Vijay Kumar51% | $615 → $600 | Maintains | Outperform | Get Alert |
06/28/2024 | Buy Now | 40.34% | Barclays | Luke Sergott52% | $615 → $600 | Maintains | Equal-Weight | Get Alert |
06/03/2024 | Buy Now | 52.04% | Jefferies | Tycho Peterson83% | $600 → $650 | Assumes | Hold → Buy | Get Alert |
04/30/2024 | Buy Now | 56.71% | HSBC | Rajesh Kumar62% | $660 → $670 | Maintains | Buy | Get Alert |
04/25/2024 | Buy Now | 52.04% | JP Morgan | Rachel Vatnsdal65% | $600 → $650 | Maintains | Overweight | Get Alert |
04/25/2024 | Buy Now | 43.85% | Barclays | Luke Sergott52% | $590 → $615 | Maintains | Equal-Weight | Get Alert |
04/25/2024 | Buy Now | 42.68% | Deutsche Bank | Justin Bowers49% | $600 → $610 | Maintains | Buy | Get Alert |
04/25/2024 | Buy Now | 45.02% | Baird | Catherine Schulte68% | $621 → $620 | Maintains | Outperform | Get Alert |
04/17/2024 | Buy Now | 54.38% | HSBC | Rajesh Kumar62% | $630 → $660 | Maintains | Buy | Get Alert |
04/10/2024 | Buy Now | 49.7% | Goldman Sachs | Matthew Sykes65% | $550 → $640 | Maintains | Buy | Get Alert |
04/04/2024 | Buy Now | 42.68% | Evercore ISI Group | Vijay Kumar51% | $575 → $610 | Maintains | Outperform | Get Alert |
03/18/2024 | Buy Now | 45.02% | Citigroup | Patrick Donnelly80% | → $620 | Reinstates | → Neutral | Get Alert |
02/01/2024 | Buy Now | 50.16% | RBC Capital | Conor McNamara38% | $592 → $642 | Maintains | Outperform | Get Alert |
02/01/2024 | Buy Now | 41.51% | Raymond James | Andrew Cooper55% | $515 → $605 | Maintains | Outperform | Get Alert |
01/24/2024 | Buy Now | 29.82% | Barclays | Luke Sergott52% | $475 → $555 | Downgrade | Overweight → Equal-Weight | Get Alert |
01/08/2024 | Buy Now | — | Bernstein | Eve Burstein44% | — | Downgrade | Outperform → Market Perform | Get Alert |
12/18/2023 | Buy Now | 42.68% | HSBC | Rajesh Kumar62% | → $610 | Initiates | → Buy | Get Alert |
12/14/2023 | Buy Now | 56.71% | Baird | Catherine Schulte68% | → $670 | Maintains | Outperform | Get Alert |
12/13/2023 | Buy Now | — | Wolfe Research | Doug Schenkel72% | — | Initiates | → Outperform | Get Alert |
12/11/2023 | Buy Now | 34.49% | Citigroup | Patrick Donnelly80% | $530 → $575 | Maintains | Buy | Get Alert |
11/06/2023 | Buy Now | 28.65% | Argus Research | David Toung71% | $540 → $550 | Maintains | Buy | Get Alert |
10/26/2023 | Buy Now | 22.56% | Baird | Catherine Schulte68% | $589 → $524 | Maintains | Outperform | Get Alert |
10/26/2023 | Buy Now | 11.1% | Barclays | Luke Sergott52% | $585 → $475 | Maintains | Overweight | Get Alert |
10/26/2023 | Buy Now | 23.97% | Stifel | Daniel Arias78% | $660 → $530 | Maintains | Buy | Get Alert |
10/26/2023 | Buy Now | 35.43% | RBC Capital | Conor McNamara38% | $657 → $579 | Maintains | Outperform | Get Alert |
10/26/2023 | Buy Now | 23.97% | Citigroup | Patrick Donnelly80% | $625 → $530 | Maintains | Buy | Get Alert |
10/26/2023 | Buy Now | 20.46% | Raymond James | Andrew Cooper55% | $580 → $515 | Maintains | Outperform | Get Alert |
10/26/2023 | Buy Now | 27.48% | Morgan Stanley | Tejas Savant50% | $600 → $545 | Maintains | Overweight | Get Alert |
10/26/2023 | Buy Now | — | Keybanc | Paul Knight55% | — | Downgrade | Overweight → Sector Weight | Get Alert |
10/25/2023 | Buy Now | 16.95% | Goldman Sachs | Matthew Sykes65% | → $500 | Maintains | Buy | Get Alert |
10/25/2023 | Buy Now | 34.49% | B of A Securities | Derik De Bruin83% | → $575 | Maintains | Buy | Get Alert |
10/24/2023 | Buy Now | 40.34% | Morgan Stanley | Tejas Savant50% | $640 → $600 | Maintains | Overweight | Get Alert |
10/23/2023 | Buy Now | 37.77% | Baird | Catherine Schulte68% | $625 → $589 | Maintains | Outperform | Get Alert |
10/18/2023 | Buy Now | 35.66% | Raymond James | Andrew Cooper55% | $630 → $580 | Maintains | Outperform | Get Alert |
10/17/2023 | Buy Now | 47.36% | JP Morgan | Rachel Vatnsdal65% | $670 → $630 | Maintains | Overweight | Get Alert |
10/16/2023 | Buy Now | 53.67% | RBC Capital | Conor McNamara38% | $685 → $657 | Maintains | Outperform | Get Alert |
10/16/2023 | Buy Now | 48.53% | B of A Securities | Derik De Bruin83% | $635 → $635 | Maintains | Buy | Get Alert |
10/12/2023 | Buy Now | 38% | Deutsche Bank | Justin Bowers49% | $620 → $590 | Maintains | Buy | Get Alert |
10/02/2023 | Buy Now | 46.19% | Citigroup | Patrick Donnelly80% | $625 → $625 | Reiterates | Buy → Buy | Get Alert |
09/29/2023 | Buy Now | 36.83% | Barclays | Luke Sergott52% | $625 → $585 | Maintains | Overweight | Get Alert |
09/28/2023 | Buy Now | 41.04% | Bernstein | Eve Burstein44% | → $603 | Initiates | → Outperform | Get Alert |
09/06/2023 | Buy Now | 46.19% | Citigroup | Patrick Donnelly80% | → $625 | Reinstates | Buy → Buy | Get Alert |
08/27/2023 | Buy Now | 60.22% | RBC Capital | Conor McNamara38% | → $685 | Maintains | Outperform | Get Alert |
08/23/2023 | Buy Now | 48.53% | B of A Securities | Derik De Bruin83% | $635 → $635 | Maintains | Buy | Get Alert |
07/28/2023 | Buy Now | 21.63% | Wells Fargo | Timothy Daley55% | $505 → $520 | Maintains | Underweight | Get Alert |
07/28/2023 | Buy Now | 47.36% | Raymond James | Andrew Cooper55% | $595 → $630 | Maintains | Outperform | Get Alert |
07/27/2023 | Buy Now | 56.71% | JP Morgan | Rachel Vatnsdal65% | $660 → $670 | Maintains | Overweight | Get Alert |
07/27/2023 | Buy Now | 54.38% | Stifel | Daniel Arias78% | $700 → $660 | Maintains | Buy | Get Alert |
07/27/2023 | Buy Now | 49.7% | Morgan Stanley | Tejas Savant50% | $620 → $640 | Maintains | Overweight | Get Alert |
07/27/2023 | Buy Now | 63.26% | RBC Capital | Conor McNamara38% | $662 → $698 | Maintains | Outperform | Get Alert |
07/27/2023 | Buy Now | 46.19% | Baird | Catherine Schulte68% | $664 → $625 | Maintains | Outperform | Get Alert |
07/27/2023 | Buy Now | 46.19% | Barclays | Luke Sergott52% | $590 → $625 | Maintains | Overweight | Get Alert |
07/26/2023 | Buy Now | 48.53% | B of A Securities | Derik De Bruin83% | → $635 | Maintains | Buy | Get Alert |
07/19/2023 | Buy Now | 55.31% | Baird | Catherine Schulte68% | $670 → $664 | Maintains | Outperform | Get Alert |
07/13/2023 | Buy Now | 45.02% | Credit Suisse | Dan Leonard56% | → $620 | Upgrade | Neutral → Outperform | Get Alert |
07/10/2023 | Buy Now | 38% | Barclays | Luke Sergott52% | $610 → $590 | Maintains | Overweight | Get Alert |
07/06/2023 | Buy Now | 52.04% | B of A Securities | Derik De Bruin83% | $650 → $650 | Maintains | Buy | Get Alert |
07/06/2023 | Buy Now | 47.36% | SVB Leerink | Puneet Souda57% | $630 → $630 | Maintains | Outperform | Get Alert |
The latest price target for Thermo Fisher Scientific (NYSE:TMO) was reported by Argus Research on April 29, 2025. The analyst firm set a price target for $470.00 expecting TMO to rise to within 12 months (a possible 9.93% upside). 46 analyst firms have reported ratings in the last year.
The latest analyst rating for Thermo Fisher Scientific (NYSE:TMO) was provided by Argus Research, and Thermo Fisher Scientific maintained their buy rating.
The last upgrade for Thermo Fisher Scientific Inc happened on July 13, 2023 when Credit Suisse raised their price target to $620. Credit Suisse previously had a neutral for Thermo Fisher Scientific Inc.
The last downgrade for Thermo Fisher Scientific Inc happened on January 24, 2024 when Barclays changed their price target from $475 to $555 for Thermo Fisher Scientific Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Thermo Fisher Scientific, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Thermo Fisher Scientific was filed on April 29, 2025 so you should expect the next rating to be made available sometime around April 29, 2026.
While ratings are subjective and will change, the latest Thermo Fisher Scientific (TMO) rating was a maintained with a price target of $620.00 to $470.00. The current price Thermo Fisher Scientific (TMO) is trading at is $427.53, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.